Several peripheral blood microarray studies have reported transcriptomic signatures associated with the presence of underlying CAD.
Recent "tiling" microarray studies have reported that a surprisingly larger proportion of mammalian genomes is transcribed than was previously anticipated.
Microarray studies have reported cyclic expression of nucleoporins, and not surprisingly, the authors report cyclic expression for a couple of other NE proteins.
Earlier microarray studies have reported that transcripts associated with ethylene signalling were up-regulated in both capsicum and tomato ripening [ 14, 15].
Moreover, studies comparing data originating from different microarray platforms have reported poor inter-platform correlations (Kuo et al, 2002; Tan et al, 2003).
While there have been several studies which evaluated LCM-coupled microarray analyses, none have reported the above observations in lung or lung adenocarcinoma [ 11, 12, 15- 18].
Baechler and colleagues have reported microarray data from 48 SLE patients and 42 healthy controls with Affymetrix U95A GeneChips [ 4].
Accordingly, several publications have reported microarray studies of peripheral blood cells to identify gene expression signatures in SLE.
A few studies have reported microarray data in biopsy material taken before and after (or even during) chemotherapy.
This workflow has been used by researchers in real microarray experiments and they have reported that the system indeed has been very useful.
